Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Benson

Showing results (741-750 of 865) with videos related to

Pageof 87
Sort By:
AIDS (London, England)|December 31, 1997
Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study GroupG J Stewart, L J Ashton, R A Biti, et al.
Journal of Clinical Medicine|October 14, 2022
Early versus Late Discontinuation of Maintenance Therapy in Multiple MyelomaJordan Nunnelee, Francesca Cottini, Qiuhong Zhao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 2009
CD94 defines phenotypically and functionally distinct mouse NK cell subsetsJianhua Yu, Min Wei, Hsiaoyin Mao, et al.
Peptides|July 1, 1993
Enhanced antiopiate activity and enzyme resistance in peptidomimetics of FMRFamide containing (E)-2,3-methanomethionineD H Malin, J R Lake, K Payza, et al.
Dimensions of Critical Care Nursing : DCCN|November 15, 2011
Using variance tracking to improve outcomes and reduce costsL M Benson, J Bowes, K Cheesebro, et al.
American Journal of Respiratory Cell and Molecular Biology|January 27, 2004
A biphasic response to silica: I. Immunostimulation is restricted to the early stage of silicosis in lewis ratsRaymond J Langley, Roma Kalra, Neerad C Mishra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
A phase I trial of single-agent reolysin in patients with relapsed multiple myelomaDouglas W Sborov, Gerard J Nuovo, Andrew Stiff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2012
Phase I trial of anti-CS1 monoclonal antibody elotuzumab in combination with bortezomib in the treatment of relapsed/refractory multiple myelomaAndrzej J Jakubowiak, Don M Benson, William Bensinger, et al.
Journal of the National Cancer Institute|March 4, 1992
Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. Isotretinoin-Basal Cell Carcinoma Study GroupJ A Tangrea, B K Edwards, P R Taylor, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|August 1, 1993
Thirteen-week, repeated inhalation exposure of F344/N rats and B6C3F1 mice to ferroceneK J Nikula, J D Sun, E B Barr, et al.
Pageof 87

Showing results (741-750 of 865) with videos related to

Sort By:
Pageof 87
AIDS (London, England)|December 31, 1997
Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study GroupG J Stewart, L J Ashton, R A Biti, et al.
Journal of Clinical Medicine|October 14, 2022
Early versus Late Discontinuation of Maintenance Therapy in Multiple MyelomaJordan Nunnelee, Francesca Cottini, Qiuhong Zhao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 2009
CD94 defines phenotypically and functionally distinct mouse NK cell subsetsJianhua Yu, Min Wei, Hsiaoyin Mao, et al.
Peptides|July 1, 1993
Enhanced antiopiate activity and enzyme resistance in peptidomimetics of FMRFamide containing (E)-2,3-methanomethionineD H Malin, J R Lake, K Payza, et al.
Dimensions of Critical Care Nursing : DCCN|November 15, 2011
Using variance tracking to improve outcomes and reduce costsL M Benson, J Bowes, K Cheesebro, et al.
American Journal of Respiratory Cell and Molecular Biology|January 27, 2004
A biphasic response to silica: I. Immunostimulation is restricted to the early stage of silicosis in lewis ratsRaymond J Langley, Roma Kalra, Neerad C Mishra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
A phase I trial of single-agent reolysin in patients with relapsed multiple myelomaDouglas W Sborov, Gerard J Nuovo, Andrew Stiff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2012
Phase I trial of anti-CS1 monoclonal antibody elotuzumab in combination with bortezomib in the treatment of relapsed/refractory multiple myelomaAndrzej J Jakubowiak, Don M Benson, William Bensinger, et al.
Journal of the National Cancer Institute|March 4, 1992
Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. Isotretinoin-Basal Cell Carcinoma Study GroupJ A Tangrea, B K Edwards, P R Taylor, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|August 1, 1993
Thirteen-week, repeated inhalation exposure of F344/N rats and B6C3F1 mice to ferroceneK J Nikula, J D Sun, E B Barr, et al.
Pageof 87